ARS Pharmaceuticals, Inc.

SPRY

SPRYARS Pharmaceuticals, Inc. US flag

NASDAQ Global Market

6.36

USD

-0.08

- -

631.57MMarket Cap

Income Statement (USD)

API ChatGPT

	2020 Y	2021 Y	2022 Y	2023 Y	2024 Y	2025 Y
As of date	12/31/2020	12/31/2021	12/31/2022	12/31/2023	12/31/2024	12/31/2025

Sales/Revenue/Turnover	18	6	1	- -	89	84
+ Sales & Services Revenue	18	6	1	- -	89	84
- Cost of Revenue	- -	- -	- -	- -	1	20
+ Cost of Goods & Services	- -	- -	- -	- -	1	20
Gross Profit	- -	- -	- -	- -	88	64
+ Other Operating Income	-18	-6	-1	- -	- -	- -
- Operating Expenses	18	25	37	68	91	243
+ Selling, General & Admin	4	5	18	47	72	230
+ Research & Development	14	20	18	20	20	13
+ Other Operating Expense	- -	- -	- -	- -	- -	- -
Operating Income (Loss)	- -	-19	-36	-68	-3	-179
- Non-Operating (Income) Loss	1	1	-1	-13	-11	-8
+ Interest Expense, Net	- -	- -	- -	- -	-11	-8
+ Interest Expense	- -	- -	- -	- -	- -	3
- Interest Income	- -	- -	- -	- -	11	11
+ Other Non-Op (Income) Loss	1	1	-1	-13	- -	- -
Pretax Income	-1	-20	-35	-54	8	-171
- Income Tax Expense (Benefit)	- -	- -	- -	- -	- -	- -
- (Income) Loss from Affiliates	- -	- -	- -	- -	- -	- -
Income (Loss) from Cont Ops	-1	-20	-35	-54	8	-171
- Net Extraordinary Losses (Gains)	- -	- -	- -	- -	- -	- -
+ Discontinued Operations	- -	- -	- -	- -	- -	- -
+ Extraord. & Accounting Changes	- -	- -	- -	- -	- -	- -
Income (Loss) Incl. MI	-1	-20	-35	-54	8	-171
- Minority Interest	- -	- -	- -	- -	- -	- -
Net Income, GAAP	-1	-20	-35	-54	8	-171
- Preferred Dividends	- -	- -	- -	- -	- -	- -
- Other Adjustments	- -	- -	- -	- -	- -	- -
Net Income Avail to Common, GAAP	-1	-20	-35	-54	8	-171
EBIT	- -	-19	-36	-68	-3	-179
EBITDA	- -	-19	-35	-74	-10	-184
EBITDA Margin (%)	-2.6	-349.46	-2,674.54	-247,650	-11.51	-217.86
EBITA	- -	-19	-36	-68	-3	-179
Gross Margin (%)	100	100	100	100	98.9	75.77
Operating Margin (%)	-2.63	-353.32	-2,698.78	-225,066.67	-3.46	-212.92
Profit Margin (%)	-5.97	-367.65	-2,635.41	-181,216.67	8.97	-203.25
Sales per Employee	- -	- -	- -	- -	- -	- -
Dividend per Share	- -	- -	- -	- -	- -	- -
Depreciation Expense	- -	- -	- -	-7	-7	-4
Basic Weighted Avg Shares	94	94	40	95	97	99
Basic EPS, GAAP	-0.01	-0.22	-0.87	-0.57	0.08	-1.74
Basic EPS from Cont Ops	-0.01	-0.22	-0.87	-0.57	0.08	-1.74
Diluted Weighted Avg Shares	94	94	40	95	102	99
Diluted EPS, GAAP	-0.01	-0.22	-0.87	-0.57	0.08	-1.74
Diluted EPS from Cont Ops	-0.01	-0.22	-0.87	-0.57	0.08	-1.74

Balance Sheet (USD)

API ChatGPT

	2020 Y	2021 Y	2022 Y	2023 Y	2024 Y	2025 Y
As of date	12/31/2020	12/31/2021	12/31/2022	12/31/2023	12/31/2024	12/31/2025

Total Current Assets	26	61	278	232	334	285
+ Cash, Cash Equivalents & STI	25	60	274	228	314	245
+ Cash & Cash Equivalents	25	60	211	71	51	41
+ ST Investments	- -	- -	64	157	263	204
+ Accounts & Notes Receiv	- -	- -	1	1	8	25
+ Accounts Receivable, Net	- -	- -	- -	- -	8	25
+ Notes Receivable, Net	- -	- -	- -	- -	- -	- -
+ Loans Receivable, Net	- -	- -	- -	- -	- -	- -
+ Other Receivable, Net	- -	- -	1	1	- -	- -
+ Inventories	- -	- -	- -	- -	5	8
+ Raw Materials	- -	- -	- -	- -	- -	- -
+ Work In Process	- -	- -	- -	- -	- -	- -
+ Finished Goods	- -	- -	- -	- -	5	- -
+ Inventory Adjustments	- -	- -	- -	- -	- -	- -
+ Other Inventory	- -	- -	- -	- -	- -	8
+ Other ST Assets	1	1	2	3	7	6
+ Misc ST Assets	- -	- -	- -	- -	- -	- -
+ Prepaid Expenses	- -	- -	- -	- -	- -	- -
+ ST Derivative & Hedging Assets	- -	- -	- -	- -	- -	- -
+ ST Assets Held-for-Sale	- -	- -	- -	- -	- -	- -
+ ST Deferred Tax Assets	- -	- -	- -	- -	- -	- -
Total Noncurrent Assets	- -	1	4	1	17	43
+ Property, Plant & Equip, Net	- -	1	1	1	1	- -
+ Property, Plant & Equip	- -	1	1	1	1	- -
- Accumulated Depreciation	- -	- -	- -	- -	- -	- -
+ LT Investments & Receivables	- -	- -	- -	- -	- -	- -
+ LT Investments	- -	- -	- -	- -	- -	- -
+ LT Receivables	- -	- -	- -	- -	- -	- -
+ Other LT Assets	- -	- -	3	1	16	43
+ Total Intangible Assets	- -	- -	- -	1	7	14
+ Goodwill	- -	- -	- -	- -	- -	- -
+ Other Intangible Assets	- -	- -	- -	1	7	14
+ LT Deferred Tax Assets	- -	- -	- -	- -	- -	- -
+ LT Derivative & Hedging Assets	- -	- -	- -	- -	- -	- -
+ Misc LT Assets	- -	- -	3	- -	8	28
Total Assets	26	61	281	233	351	328
+ Payables & Accruals	2	2	4	2	23	38
+ Accounts Payable	1	2	2	1	10	6
+ Accrued Taxes	- -	- -	- -	- -	- -	- -
+ Interest & Dividends Payable	- -	- -	- -	- -	- -	- -
+ Other Payables & Accruals	1	1	3	1	13	32
+ ST Debt	3	4	- -	- -	- -	- -
+ ST Borrowings	3	3	- -	- -	- -	- -
+ ST Finance Leases	- -	- -	- -	- -	- -	- -
+ Other ST Liabilities	4	2	1	- -	1	1
+ Deferred Revenue	4	1	- -	- -	1	1
+ Derivatives & Hedging	- -	- -	- -	- -	- -	- -
+ Deferred Tax Liabilities	- -	- -	- -	- -	- -	- -
+ Misc ST Liabilities	- -	1	- -	- -	- -	1
Total Current Liabilities	8	8	5	2	23	39
+ LT Debt	7	5	- -	- -	- -	96
+ LT Borrowings	7	5	- -	- -	- -	96
+ LT Finance Leases	- -	- -	- -	- -	- -	- -
+ Other LT Liabilities	25	79	3	- -	71	78
+ Accrued Liabilities	3	3	3	- -	2	1
+ Pension Liabilities	- -	- -	- -	- -	- -	- -
+ Deferred Revenue	- -	- -	- -	- -	- -	- -
+ Deferred Tax Liabilities	- -	- -	- -	- -	- -	- -
+ Derivatives & Hedging	- -	- -	- -	- -	- -	- -
+ Misc LT Liabilities	21	76	- -	- -	69	77
Total Noncurrent Liabilities	32	85	3	- -	71	174
Total Liabilities	40	93	9	2	94	213
+ Preferred Equity and Hybrid Capital	- -	- -	- -	- -	- -	- -
+ Share Capital & APIC	8	11	349	362	380	409
+ Common Stock	- -	- -	- -	- -	- -	- -
+ Additional Paid in Capital	8	11	349	362	380	409
- Treasury Stock	- -	- -	- -	- -	- -	- -
+ Retained Earnings	-22	-42	-77	-131	-123	-295
+ Other Equity	- -	- -	- -	- -	- -	- -
Equity Before Minority Interest	-14	-31	273	231	257	114
+ Minority/Non Controlling Interest	- -	- -	- -	- -	- -	- -
Total Equity	-14	-31	273	231	257	114
Total Liabilities & Equity	26	61	281	233	351	328
Shares Outstanding	94	94	94	96	98	99
Number of Employees	- -	- -	- -	- -	- -	- -
Capital Leases - Total	- -	1	- -	- -	- -	- -
Net Debt	-15	-52	-211	-71	-51	55
Net Debt to Equity	103.21	165.19	-77.15	-30.76	-19.79	48.19
Tangible Common Equity Ratio	-53.21	-50.89	96.96	98.96	72.55	31.87
Current Ratio	3.21	7.42	51.01	96.92	14.26	7.28
Cash Conversion Cycle	- -	- -	- -	- -	676.89	73.25

Cash Flow Statement (USD)

API ChatGPT

	2020 Y	2021 Y	2022 Y	2023 Y	2024 Y	2025 Y
As of date	12/31/2020	12/31/2021	12/31/2022	12/31/2023	12/31/2024	12/31/2025

+ Net Income	-1	-20	-35	-54	8	-171
+ Depreciation & Amortization	- -	- -	- -	-7	-7	-4
+ Non-Cash Items	4	3	7	9	15	25
+ Stock-Based Compensation	4	3	6	9	15	22
+ Deferred Income Taxes	- -	- -	- -	- -	- -	- -
+ Asset Impairment Charge	- -	- -	- -	- -	- -	- -
+ Other Non-Cash Adj	- -	- -	1	- -	- -	2
+ Chg in Non-Cash Work Cap	6	- -	-13	-7	-2	-20
+ (Inc) Dec in Accts Receiv	- -	- -	- -	- -	-8	-17
+ (Inc) Dec in Inventories	- -	- -	- -	- -	-6	-22
+ (Inc) Dec in Prepaid Assets	-2	1	-1	-1	-6	1
+ Inc (Dec) in Accts Payable	1	1	-10	-3	16	19
+ Inc (Dec) in Other	7	-3	-1	-3	2	- -
+ Net Cash From Disc Ops	- -	- -	- -	- -	- -	- -
Cash from Operating Activities	9	-18	-40	-59	14	-171
+ Change in Fixed & Intang	- -	- -	- -	- -	- -	- -
+ Disp in Fixed & Intang	- -	- -	- -	- -	- -	- -
+ Disp of Fixed Prod Assets	- -	- -	- -	- -	- -	- -
+ Disp of Intangible Assets	- -	- -	- -	- -	- -	- -
+ Acq of Fixed & Intang	- -	- -	- -	- -	-1	- -
+ Acq of Fixed Prod Assets	- -	- -	- -	- -	-1	- -
+ Acq of Intangible Assets	- -	- -	- -	- -	- -	- -
+ Cash (Repurchase) of Equity	- -	- -	- -	- -	- -	- -
+ Increase in Capital Stock	- -	- -	- -	- -	- -	- -
+ Decrease in Capital Stock	- -	- -	- -	- -	- -	- -
+ Net Change in LT Investment	- -	- -	- -	-87	-98	65
+ Dec in LT Investment	- -	- -	- -	185	258	307
+ Inc in LT Investment	- -	- -	- -	-272	-356	-242
+ Net Cash From Acq & Div	- -	- -	- -	- -	- -	- -
+ Cash from Divestitures	- -	- -	- -	- -	- -	- -
+ Cash for Acq of Subs	- -	- -	- -	- -	- -	- -
+ Cash for JVs	- -	- -	- -	- -	- -	- -
+ Other Investing Activities	- -	- -	- -	- -	-8	-8
+ Net Cash From Disc Ops	- -	- -	- -	- -	- -	- -
Cash from Investing Activities	- -	- -	- -	-87	-106	57
+ Dividends Paid	- -	- -	- -	- -	- -	- -
+ Net Cash From Debt	5	-2	-9	- -	- -	96
+ Cash From Debt	5	- -	- -	- -	- -	96
+ Repayments of Debt	- -	-2	-9	- -	- -	- -
+ Other Financing Activities	- -	55	199	7	72	8
+ Net Cash From Disc Ops	- -	- -	- -	- -	- -	- -
Cash from Financing Activities	5	53	191	7	72	105
Effect of Foreign Exchange Rates	- -	- -	- -	- -	- -	- -
Net Changes in Cash	14	36	150	-140	-20	-10
EBITDA	- -	-19	-35	-74	-10	-184
EBITDA Margin (%)	-2.6	-349.46	-2,674.54	-247,650	-11.51	-217.86
Free Cash Flow	9	-18	-40	-59	13	-171
Net Cash Paid for Acquisitions	- -	- -	- -	- -	- -	- -
Free Cash Flow to Firm	- -	- -	- -	- -	13	- -
Free Cash Flow to Equity	- -	-19	-49	-59	13	-75
Free Cash Flow per Basic Share	0.1	-0.19	-1.01	-0.62	0.13	-1.74
Price/Free Cash Flow	479.03	-35.67	-8.55	-8.83	76.55	-6.73
Cash Flow to Net Income	-8.52	0.87	1.16	1.09	1.69	1
Capital Expenditures	- -	- -	- -	- -	-1	- -